Genetic study on Alzheimer's identifies new risk loci


Friday, 20 November, 2026


Genetic study on Alzheimer's identifies new risk loci

A large-scale international study into Alzheimer’s has identified 127 regions in human DNA associated with the risk of developing the disease — 48 of which had not previously been mapped in this context.

These findings, published in the journal Nature, provide researchers with a deeper understanding of the biological processes that contribute to the onset of the disease and may aid in the development of new therapies.

For this study, the researchers analysed genetic data from approximately 2.8 million individuals, including 183,620 people with Alzheimer’s. According to first author Douglas Wightma, from Vrije Universiteit Amsterdam, “This is the largest genetic association study on Alzheimer’s to date, bringing together data from individuals with diverse genetic backgrounds.”

The results of the study underscore the role of microglia — immune cells in the brain involved in tasks such as clearing away harmful substances and damaged cellular material. As explained by research lead Danielle Posthuma, also from Vrije Universiteit Amsterdam, “We discovered new genetic evidence for processes related to the activation of these cells, the recruitment of immune cells, and the clearance of material within the brain. This helps us better understand how the immune system may contribute to the onset and progression of Alzheimer’s.”

In addition, the researchers identified genes linked to other key processes in the brain. For instance, there is evidence of involvement in the processing of amyloid — a protein that can accumulate in the brain in cases of Alzheimer’s — as well as in the repair of nerve cells. The researchers also discovered genetic associations with the activation of astrocytes (supporting brain cells) and the maintenance of the protective insulating layer surrounding nerve fibres.

Importantly, the researchers identified several specific types of neurons that are enriched for genetic signal and may play a key role in the development of Alzheimer’s disease. This opens up new directions for investigating how the disease develops.

“We already knew that immune processes play an important role in Alzheimer’s disease,” Posthuma said. “What makes this study particularly valuable is that we can now connect new genetic risk factors to more specific biological processes, while also uncovering evidence pointing to the involvement of other brain cell types. This gives us a more detailed picture of the biology underlying Alzheimer’s and provides new directions for investigating potential treatments.”

The study also shows that common genetic variants contribute considerably more to Alzheimer’s risk than previously estimated. The researchers estimate that together these variants explain about 16% of the differences in Alzheimer’s risk between people. That is nearly three times earlier estimates of around 5%, which had led some to suggest there was little left to discover with this type of research. The higher estimate comes mainly from a statistical method that better accounts for APOE, a gene with an unusually large effect on Alzheimer’s risk.

“This shows that large genetic studies still have more to find than some assumed,” said co-first author Emil Uffelmann, from Vrije Universiteit Amsterdam. “But it is a population-level figure. It does not mean that 16% of any one person’s Alzheimer’s is caused by their genes, and it does not mean a genetic test can determine whether someone will develop the disease. Age, environment and other biological and personal factors also play an important role.”

Although genetic factors play a significant role in the risk of developing Alzheimer’s, it is not yet fully understood which specific genes and biological processes cause or influence the disease. These new findings will help researchers more precisely identify which genes and processes warrant further investigation.

The study was conducted under the umbrella of the international Psychiatric Genomics Consortium, whose Alzheimer’s disease working group is co-led by Posthuma and Ole Andreassen of the University of Oslo. By pooling data from 30 research groups, the investigators were able to detect genetic associations that might have gone unnoticed in smaller-scale studies. The researchers have also emphasised the importance of continued investment in large-scale genetic research, with particular attention given to population groups that have thus far been underrepresented in scientific studies.

Image credit: iStock.com/Love Employee

Related Articles

New species of bacteria discovered in prostate cancer patients

Researchers have discovered the genetic blueprints of 18 new bacterial species in prostate cancer...

Award-winning system automates vial filling for cell therapy

Celleo's Larkem V40 — created to address one of the bottlenecks holding back cell...

Air pollutant exposure linked to glaucoma, cataracts and suicide

People who are exposed to high levels of air pollution are more likely to develop glaucoma and...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd